19 data-science-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" positions at Amsterdam UMC
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
sensitive to disruption of the RNA splicing machinery. The project combines molecular biology, cell biology and genomics with state-of-the-art technologies such as confocal microscopy and (single-cell) RNA
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
models that combine anatomical and hemodynamic information derived from routine clinical imaging. By providing quantitative insights into coronary anatomy, blood flow, pressure, and wall shear stress
-
multidisciplinary network of researchers within the departments of Molecular Cell Biology & Immunology and Pathology at Amsterdam UMC. Would you like to know more about the different phases within the PhD trajectory
-
department is highly interdisciplinary with informatics researchers working closely together with practicing cardiologists to advance the use of AI for personalised treatment. The ultimate goal is to be able
-
remodels and heals under controlled in vitro conditions. In the first phase, you will validate and implement the BBoC technology. In the translational phase, you will study how a candidate pharmaceutical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient